ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269757; 2) Community: the network communities that were significantly associated with the response to NSC 269757; 3) Molecule: the relationships between components within communities and NSC 269757; 4) MDR: the compounds that were significantly associated with the NSC 269757.

NSC Compound Enrichment Correlation
NSC 718890 Null 0.0152777849043087 0.34837647
NSC 719381 Null 0.0152777849043087 0.22906207
NSC 722568 Null 0.0152777849043087 0.52117093
NSC 733154 Null 0.0152777849043087 0.37285005
NSC 748148 5-iodo-2-{[(2)-3-(2-chlorophenyl)prop-2-enoyl]amino}benzamide 0.0152777849043087 0.41417891
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0152777849043087 0.17857041
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0152777849043087 0.18766139
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0152777849043087 0.3086695
NSC 13479 Null 0.0162638908166157 0.34336825
NSC 174121 Methotrexate Derivative 0.0162638908166157 -0.012401628
Total:74  Current:32    [First] [Prev] [Next] [Last]